<DOC>
	<DOCNO>NCT00000381</DOCNO>
	<brief_summary>The purpose study see safe effective use fluoxetine treat child adolescent Generalized Anxiety Disorder ( GAD ) . Anxiety disorder one common psychiatric disorder child adolescent , cause disturbance child 's school , social , family life . Having anxiety disorder put child risk depression drug abuse , appear continue adulthood . There little information anxiety medication child . Children assign randomly ( like toss coin ) receive either fluoxetine inactive placebo 12 week . Each child monitor symptom side effect throughout study . He/she blood test Weeks 4 , 8 , 12 measure drug level blood . The study last 12 week . A child eligible study he/she : Is 8 17 year old anxiety disorder . A child eligible study he/she : Has current major depression , panic disorder , obsessive-compulsive disorder , abuse alcohol drug .</brief_summary>
	<brief_title>Fluoxetine Anxious Children</brief_title>
	<detailed_description>To evaluate safety efficacy fluoxetine treatment child adolescent Generalized Anxiety Disorder ( GAD ) . Anxiety disorder among common childhood adolescent psychiatric disorder often associate academic , social , family morbidity . These disorder frequently increase risk develop psychiatric disorder ( e.g. , depression , substance abuse ) , aggregate family , appear continue adulthood . Except Obsessive-Compulsive Disorder , pharmacological treatment study childhood anxiety disorder . Given sparsity methodological problem previous anxiety pharmacological study , clear investigation use pharmacological treatment child adolescents disorder need . Patients randomize receive either fixed-dose fluoxetine placebo 12 week . Patients assess psychiatric symptomatology , functional status , side effect . In addition , assess attainment steady state compliance treatment , plasma level fluoxetine norfluoxetine measure 4 , 8 , 12 week . To standardize treatment protocol assure group ( fluoxetine placebo ) receive equivalent nonpharmacological treatment , manual use . Potential predictor clinical response ( age , sex , duration severity anxiety , school absenteeism , sub-syndromal depressive symptom , family history anxiety mood disorder ) explore .</detailed_description>
	<mesh_term>Anxiety Disorders</mesh_term>
	<mesh_term>Serotonin</mesh_term>
	<mesh_term>Fluoxetine</mesh_term>
	<mesh_term>Serotonin Uptake Inhibitors</mesh_term>
	<criteria>Patients must : Generalized anxiety disorder . Excluded : Patients current major depression , well patient panic obsessivecompulsive disorder . Excluded : Current substance abuse .</criteria>
	<gender>All</gender>
	<minimum_age>8 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>December 2005</verification_date>
	<keyword>Adolescence</keyword>
	<keyword>Anxiety Disorders</keyword>
	<keyword>Child</keyword>
	<keyword>Female</keyword>
	<keyword>Fluoxetine</keyword>
	<keyword>Male</keyword>
	<keyword>Placebos</keyword>
	<keyword>Serotonin Uptake Inhibitors</keyword>
	<keyword>Anxiety Disorders -- *drug therapy</keyword>
	<keyword>Fluoxetine -- *therapeutic use</keyword>
	<keyword>Serotonin Uptake Inhibitors -- *therapeutic use</keyword>
</DOC>